Drugs, Medical Devices, Biologics Archives - Page 27 of 39

Medical Device Crowdfunding and Pre-Approval Promotion: Where Does FDA Draw the Line?
Gallery
Medical Device Crowdfunding and Pre-Approval Promotion: Where Does FDA Draw the Line?

Archived Publication, Drugs, Medical Devices, Biologics, Interest, Publications, Update Magazine, Update October/November 2018

Medical Device Crowdfunding and Pre-Approval Promotion: Where Does FDA Draw the Line?

Update Magazine | October/November 2018

Medical Device Crowdfunding and Pre-Approval Promotion: Where Does FDA Draw the Line?admin2018-12-04T10:17:20-05:00

Epidiolex Approval Suggests the Way Forward for Marijuana-Derived Products
Gallery
Epidiolex Approval Suggests the Way Forward for Marijuana-Derived Products

Archived Publication, Drugs, Medical Devices, Biologics, Interest, Publications, Update Magazine, Update October/November 2018

Epidiolex Approval Suggests the Way Forward for Marijuana-Derived Products

Update Magazine | October/November 2018

Epidiolex Approval Suggests the Way Forward for Marijuana-Derived Productsadmin2018-11-30T11:51:23-05:00

Digital Health – FDA’s Approach Will Continue to Evolve
Gallery
Digital Health – FDA’s Approach Will Continue to Evolve

Archived Publication, Drugs, Medical Devices, Biologics, Interest, Publications, Update Magazine, Update October/November 2018

Digital Health – FDA’s Approach Will Continue to Evolve

Update Magazine | October/November 2018

Digital Health – FDA’s Approach Will Continue to Evolveadmin2018-11-30T11:51:23-05:00

Case Study: Jazz Pharmaceuticals v. Amneal Pharmaceuticals
Gallery
Case Study: Jazz Pharmaceuticals v. Amneal Pharmaceuticals

Archived Publication, Drugs, Medical Devices, Biologics, Interest, Publications, Update Magazine, Update October/November 2018

Case Study: Jazz Pharmaceuticals v. Amneal Pharmaceuticals

Update Magazine | October/November 2018

Case Study: Jazz Pharmaceuticals v. Amneal Pharmaceuticalsadmin2018-11-30T11:51:24-05:00

Student Corner: Right to Try Act: Is it the Answer for Terminally Ill Patients?
Gallery
Student Corner: Right to Try Act: Is it the Answer for Terminally Ill Patients?

Archived Publication, Drugs, Medical Devices, Biologics, Interest, Publications, Update Magazine, Update October/November 2018

Student Corner: Right to Try Act: Is it the Answer for Terminally Ill Patients?

Update Magazine | October/November 2018

Student Corner: Right to Try Act: Is it the Answer for Terminally Ill Patients?admin2018-11-30T11:51:24-05:00

Global Focus: Clinical Trials in India
Gallery
Global Focus: Clinical Trials in India

Archived Publication, Drugs, Medical Devices, Biologics, Interest, Publications, Update Magazine, Update October/November 2018

Global Focus: Clinical Trials in India

Update Magazine | October/November 2018

Global Focus: Clinical Trials in Indiaadmin2018-11-30T11:51:25-05:00

From Approval to Coverage – FDA and CMS Jurisdictional Lines
Gallery
From Approval to Coverage – FDA and CMS Jurisdictional Lines

Drugs, Medical Devices, Biologics, Event, Food, Dietary Supplements, Cosmetics, Medical Products Webinars, On-demand Webinar, Tobacco Products

From Approval to Coverage – FDA and CMS Jurisdictional Lines

Recorded September 27, 2018 | On-Demand Webinar

From Approval to Coverage – FDA and CMS Jurisdictional Linesadmin2024-07-19T10:07:05-04:00

When Markets Fail: Patents and Infectious Disease Products (Open Access)
Gallery
When Markets Fail: Patents and Infectious Disease Products (Open Access)

Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Journal 73.3, Publications

When Markets Fail: Patents and Infectious Disease Products (Open Access)

Food and Drug Law Journal | Volume 73 | Number 3

When Markets Fail: Patents and Infectious Disease Products (Open Access)admin2021-07-22T15:40:21-04:00

Buying and Selling Prioritized Regulatory Review: The Market for Priority Review Vouchers as Quasi-Intellectual Property (Open Access)
Gallery
Buying and Selling Prioritized Regulatory Review: The Market for Priority Review Vouchers as Quasi-Intellectual Property (Open Access)

Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Journal 73.3, Publications

Buying and Selling Prioritized Regulatory Review: The Market for Priority Review Vouchers as Quasi-Intellectual Property (Open Access)

Food and Drug Law Journal | Volume 73 | Number 3

Buying and Selling Prioritized Regulatory Review: The Market for Priority Review Vouchers as Quasi-Intellectual Property (Open Access)admin2021-07-22T15:40:30-04:00

Obsolete to Useful to Obsolete Once Again: A History of Section 507 of the Food, Drug, and Cosmetic Act
Gallery
Obsolete to Useful to Obsolete Once Again: A History of Section 507 of the Food, Drug, and Cosmetic Act

Archived Publication, Drugs, Medical Devices, Biologics, Food and Drug Law Journal, Journal 73.3, Publications

Obsolete to Useful to Obsolete Once Again: A History of Section 507 of the Food, Drug, and Cosmetic Act

Food and Drug Law Journal | Volume 73 | Number 3

Obsolete to Useful to Obsolete Once Again: A History of Section 507 of the Food, Drug, and Cosmetic Actadmin2021-04-21T10:51:16-04:00